Pliva
{{Short description|Croatian pharmaceutical company}}
{{About|the Croatian company|the river in Bosnia and Herzegovina|Pliva (river)|the waterfall in Bosnia and Herzegovina|Pliva Waterfall|the Beninese actor, stage director and playwright|José Pliva}}
{{Infobox company
| name = Pliva d.o.o.
| logo = PLIVA Logo.svg
| type = Subsidiary
| industry = Pharmaceutical industry
| parent = Teva Pharmaceuticals
| foundation = {{Start date and age|1921}}
| key_people = Mihael Furjan (CEO)
| num_employees = 1,700
| products = Generic drugs
| revenue = $1.174 billion (2005)
| net_income = $0.336 billion (2005)
| homepage = {{url|http://www.pliva.com/}}
| footnotes = {{cite web | url=http://www.pliva.com/press/company-profile | title=Company Profile | publisher=Pliva}}
}}
File:Sumamed tablete 091208.jpg
Pliva d.o.o. is a pharmaceutical company based in Zagreb, Croatia that primarily manufactures and sells generic drugs. It is a subsidiary of Teva Pharmaceuticals.
Pliva is one of the world's largest producers of generic Adderall.{{citation needed|date=May 2020}}
History
The company was founded in 1921.
A team of Pliva's researchers, Gabrijela Kobrehel, Gorjana Radobolja-Lazarevski and Zrinka Tamburašev led by Dr. Slobodan Đokić, discovered azithromycin in 1980.{{Cite journal |last=Mutak |first=Stjepan |date=2007 |title=Azalides from Azithromycin to New Azalide Derivatives |url=https://www.nature.com/articles/ja200710 |journal=The Journal of Antibiotics |language=en |volume=60 |issue=2 |pages=85–122 |doi=10.1038/ja.2007.10 |issn=0021-8820}}
In June 2002, the company acquired Sidmak for $152.9 million.{{cite press release | url=http://www.pliva.com/press/news/article/587/PLIVA-announces-acquisition-of-US-based-Sidmak.html | title=PLIVA announces acquisition of US-based Sidmak | publisher=Pliva | date=June 11, 2002}}
Also in June 2002, Zeljko Peric, the chief financial officer of the company, resigned.{{cite press release | url=http://pliva.com/press/news/article/548/PLIVA-announces-management-changes.html | title=PLIVA announces management changes | publisher=Pliva | date=June 27, 2002}}
In May 2004, the company received approval from the Food and Drug Administration to sell trospium chloride.{{cite press release | url=http://www.pliva.com/press/news/article/610/PLIVA-Announces-FDA-Approval-of-SANCTURA.html | title=PLIVA Announces FDA Approval of SANCTURA | publisher=Pliva | date=May 31, 2004}}
In June 2005, the company received approval to sell a generic version of erythropoietin in Croatia.{{cite press release | url=http://www.pliva.com/press/news/article/735/PLIVA-Registers-generic-EPO-in-Croatia.html | title=PLIVA Registers generic EPO in Croatia | publisher=Pliva | date=June 21, 2005}}
In November 2005, the company received approval from the Food and Drug Administration to sell a generic version of Azithromycin,{{cite press release | url=http://www.pliva.com/press/news/article/760/PLIVA-Announces-Approval-for-Azithromycin-Tablets.html | title=PLIVA Announces Approval for Azithromycin Tablets | publisher=Pliva | date=November 15, 2005}} Citalopram,{{cite press release | url=http://www.pliva.com/press/news/article/754/PLIVA-Announces-Approval-for-Citalopram-Hydrobromide-Tablets.html | title=PLIVA Announces Approval for Citalopram Hydrobromide Tablets | publisher=Pliva | date=November 3, 2005}} and Ondansetron.{{cite press release | url=http://www.pliva.com/press/news/article/761/PLIVA-Announces-Approval-for-Ondansetron-Hydrochloride-ODT.html | title=PLIVA Announces Approval for Ondansetron Hydrochloride ODT | publisher=Pliva | date=November 21, 2005}}
In October 2006, Barr Pharmaceuticals acquired Pliva.{{cite press release | url=http://www.pliva.com/press/news/article/825/Barr-Acquires-PLIVA-dd.html | title=Barr Acquires PLIVA d.d. | publisher=Pliva | date=October 12, 2006}}
On December 23, 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceuticals and the company became part of Teva Active Pharmaceutical Ingredients (TAPI).{{cite press release | url=http://www.pliva.com/press/news/article/888/TEVA-COMPLETES-ACQUISITION-OF-BARR.html | title=TEVA COMPLETES ACQUISITION OF BARR | publisher=Pliva | date=December 23, 2008}}